Myungin Pharm

Myungin Pharm is a prominent South Korean pharmaceutical company that specializes in the development, manufacturing, and marketing of Central Nervous System (CNS) and cardiovascular medications. Established in 1985, the company has grown into a market leader in the Korean CNS sector, offering a comprehensive portfolio of antipsychotics, antidepressants, and antiepileptics. Myungin Pharm operates advanced cGMP-compliant manufacturing facilities in Hwaseong, which produce both finished dosage forms and active pharmaceutical ingredients (APIs). The company is well-known for its strong brand recognition in Korea, supported by successful products like the gum health treatment Igatan and various psychiatric generics. With a focus on high-quality formulation technology and R&D, Myungin Pharm continues to expand its presence in both domestic and international markets. The company maintains high profitability and is recognized for its significant investment in specialized therapeutic areas.